-Meng How Tan Researcher Activity Profile

Research Author Detailed Information 

Meng How Tan Publication Rate By Year

Meng How Tan has published 1 paper(s) in 1997, 2 paper(s) in 1998, 21 paper(s) in 2007, 2 paper(s) in 2008, for a total of 26 research publications in total.

Meng How Mh Tan Author Information

LAST NAME: tan

FIRST NAME: Meng How

INITIALS: mh

AFFILIATION:

Papers

Meng How Tan's Publication Record

1. High-throughput identification of transcription start sites, conserved promoter motifs and predicted regulons. Year Published: 2007
Department of Physics, Stanford University, Varian Physics, 382 Via Pueblo Mall, Stanford, California 94305, USA.
2. Identification of deregulated oncogenic pathways in renal cell carcinoma: an integrated oncogenomic approach based on gene expression profiling. Year Published: 2007
Laboratory of Computational Biology, Van Andel Research Institute, 333 Bostwick Avenue N.E., Grand Rapids, MI 49503, USA. kyle.furge@vai.org.and
3. Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas. Year Published: 2007
Department of Pathology, Leiden University Medical Centre, The Netherlands.
4. PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK. Year Published: 2007
Center for Outcomes Research, A Unit of IMS Health, Allschwil, Switzerland.
5. Effects of blood glucose rate of changes on perceived mood and cognitive symptoms in insulin-treated type 2 diabetes. Year Published: 2007
Psychiatry and Neurobehavioral Sciences, University of Virginia Health Sciences Center, Charlottesville, VA, USA. djc4f@virginia.edu
6. Optimizing the use of local muscle flaps for knee megaprosthesis coverage. Year Published: 2007
Department of Plastic, Reconstructive and Aesthetic Surgery, Singapore General Hospital, Singapore.
7. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison. Year Published: 2007
Eli Lilly and Company, Indianapolis, Indiana 46285, USA. ilagll@lilly.com
8. [Inhibition of activator protein 4 gene expression by RNA interference in human colon carcinoma cell line SW480.] Year Published: 2007
Department of Gastrointestinal Surgery, The First Municipal Peopleos Hospital of Guangzhou, Guangzhou Medical College, Guangzhou 510180, China. czhongt@126.com.
9. Prandial premixed insulin analogue regimens versus Basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison. Year Published: 2007
Eli Lilly and Company, Indianapofis, Indiana.
10. Recruitment to a clinical trial improves glycemic control in patients with diabetes. Year Published: 2007
Department of Diabetes and Metabolism, University of Bristol, Bristol, UK. edwin.gale@bristol.ac.uk
11. PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK. Year Published: 2007
Center for Outcomes Research, A Unit of IMS Health, Allschwil, Switzerland.
12. [Inhibition of activator protein 4 gene expression by RNA interference in human colon carcinoma cell line SW480] Year Published: 2007
Department of Gastrointestinal Surgery, The First Municipal People's Hospital of Guangzhou, Guangzhou Medical College, Guangzhou, China. czhongt@126.com
13. Parafibromin expression in breast cancer: a novel marker for prognostication? Year Published: 2007
Department of Pathology, Singapore General Hospital, Singapore.
14. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA(1c) and pre- and postprandial blood glucose levels in patients with type 2 diabetes: A multinational, 24-week, randomized, open-label, parallel-group comparison. Year Published: 2007
Diabetes and Endocrine Platform Team, Eli Lilly and Company, Indianapolis, Indiana; Currently, Department of Medicine, Section of Endocrinology, Kansas University Medical School, Kansas City, Kansas.
15. Parafibromin expression in breast cancer: a novel marker for prognostication? Year Published: 2007
Department of Pathology, Singapore General Hospital, Singapore.
16. Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis. Year Published: 2008
Department of Medical Oncology, National Cancer Centre, Singapore. soonthyelim@yahoo.com
17. Optimizing the use of local muscle flaps for knee megaprosthesis coverage. Year Published: 2007
Department of Plastic, Reconstructive and Aesthetic Surgery, Singapore General Hospital, Singapore.
18. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison. Year Published: 2007
Diabetes and Endocrine Platform Team, Eli Lilly and Company, Indianapolis, IN 46285, USA.
19. Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis. Year Published: 2008
Department of Medical Oncology, National Cancer Centre, Singapore. soonthyelim@yahoo.com
20. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison. Year Published: 2007
Eli Lilly and Company, Indianapolis, Indiana 46285, USA. ilagll@lilly.com
21. Parafibromin expression in breast cancer: a novel marker for prognostication? Year Published: 2007
Department of Pathology, Singapore General Hospital, Singapore.
22. Recruitment to a clinical trial improves glycemic control in patients with diabetes. Year Published: 2007
Department of Diabetes and Metabolism, University of Bristol, Bristol, UK. edwin.gale@bristol.ac.uk
23. Accuracy of CT-guided needle biopsy of musculoskeletal neoplasms. Year Published: 1998
Radiology Department, Connective Tissue Oncology Center, Massachusetts General Hospital, Boston 02114, USA.
24. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, rand? Year Published: 2007
Diabetes and Endocrine Platform Team, Eli Lilly and Company, Indianapolis, IN 46285, USA.
25. Reverse cholesterol transport: its contribution to cholesterol catabolism in normal and disease states. Year Published: 1997
Department of Medicine, Dalhousie University, Halifax, Nova Scotia.
26. Relation of HFE gene mutations, high iron stores and early onset coronary artery disease. Year Published: 1998
Department of Pathology, Dalhousie University Faculty of Medicine, Halifax, Nova Scotia. nassar@is.dal.ca